Mynaric AG header image

Mynaric AG

M0YN

Equity

ISIN DE000A31C305 / Valor 121337525

Xetra (2025-08-01)
EUR 0.17%

Mynaric AG
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

Mynaric AG, a company publicly traded on both the Nasdaq and Frankfurt stock exchanges, specializes in the development and manufacturing of optical communications terminals for a variety of applications including terrestrial, mobility, airborne, and space-based platforms. Founded in 2009 and headquartered in Munich, Germany, with additional facilities in Los Angeles, California, and Washington, D.C., Mynaric aims to revolutionize data transmission through its laser communication networks. These networks are designed to enable ultra-high data rates and secure, long-distance data exchange between moving objects, enhancing connectivity across the globe. Over the years, Mynaric has achieved significant technological milestones, including setting world records for air-to-ground data transmission speeds in collaboration with notable partners such as Airbus/Cassidian and Facebook. The company's growth trajectory has been marked by its initial public offering on the Frankfurt stock exchange, followed by an IPO on Nasdaq, and the establishment of its first serial production facility, positioning Mynaric as a leader in the industrialization of laser communication systems.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (07.02.2026):

Mynaric AG — FY 2023 results (full year 2023; presentation dated June 20, 2024). The company reported FY 2023 revenue of €5.4 million, an operating loss of €79.2 million and cash-in from customer contracts of €49.2 million. At year‑end the optical communications terminal backlog stood at 794 units. For FY 2024 Mynaric guided to revenue of €50–70 million, an operating loss of €40–30 million (loss), cash‑in from customer contracts of €65–100 million and backlog of 800–1,000 terminals. Management highlighted the first unit shipment in Q1 2024 and a ramp toward serial production, while noting potential financing needs if production or order timelines slip.

Revenue and FY2024 outlook

FY 2023 revenue: €5.4M. FY 2024 guidance: revenue expected between €50M and €70M, reflecting the planned production ramp and customer program deliveries.

Profitability

FY 2023 operating loss: €79.2M. FY 2024 expected operating loss: between €40M and €30M (i.e., narrower loss as revenue scales).

Cash, cash‑in and backlog

Cash‑in from customer contracts in FY 2023: €49.2M. FY 2023 optical communications terminal backlog: 794 units. FY 2024 targets: €65–100M cash‑in and backlog of 800–1,000 units.

Commercial and operational progress

Management reported the first unit shipment in Q1 2024, multiple government awards, the strongest pipeline in company history and a focus on ramping serial production and operational excellence.

Financing and risk notice

The FY 2024 outlook is conditioned on the planned production ramp and liquidity projection; Mynaric warns that production delays or slower order intake would likely require raising additional capital and it is considering multiple options to secure cash needs.

Summarized from source with an LLMView Source

Key figures

-98.9%1Y
-99.5%3Y
-99.7%5Y

Performance

377%1Y
203%3Y
155%5Y

Volatility

Market cap

9 M

Market cap (USD)

Daily traded volume (Shares)

Daily traded volume (Shares)

1 day high/low

1.585 / 1.255

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
2.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
2.00
Leonardo Ceresa
Switzerland, 04 Mar 2025
star star star star star
Ich finde es ein gutes Anlageinstrument

EQUITIES OF THE SAME SECTOR

Spyre Therapeutics Inc
Spyre Therapeutics Inc Spyre Therapeutics Inc Valor: 129513338
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.24%USD 44.18
Meyer Burger Technology Ltd
Meyer Burger Technology Ltd Meyer Burger Technology Ltd Valor: 135706599
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-74.74%CHF 0.0048
Charles River Laboratories International Inc
Charles River Laboratories International Inc Charles River Laboratories International Inc Valor: 1097832
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.20%USD 163.52
Spirent Communications PLC
Spirent Communications PLC Spirent Communications PLC Valor: 1076425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%GBP 1.99
AddLife AB
AddLife AB AddLife AB Valor: 54724459
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.07%SEK 143.70
NVIDIA Corp
NVIDIA Corp NVIDIA Corp Valor: 994529
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.91%USD 191.55
BlackLine Inc
BlackLine Inc BlackLine Inc Valor: 34173457
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.96%USD 32.55
LegalZoom.com Inc
LegalZoom.com Inc LegalZoom.com Inc Valor: 19113587
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.03%USD 6.23
Dynatrace Inc
Dynatrace Inc Dynatrace Inc Valor: 48876542
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.97%USD 33.64
Biotage AB
Biotage AB Biotage AB Valor: 3011313
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%SEK 143.20